MicroRNA-29a and microRNA-122 expressions and other inflammatory markers among obese children with diabetes

Nervana M K Bayoumy1, Mohamed M El-Shabrawi2, Wafaa Elsayed3

  • 1Physiology Department, College of Medicine, Center of Excellence in Thrombosis & Hemostasis, King Saud University, Riyadh, Kingdom of Saudi Arabia.

Insights

Obese children with diabetes show higher microRNA-29a and microRNA-122 levels and inflammatory markers, but lower sestrin-2. These microRNAs may play a role in childhood obesity development.

Area of Science:

  • Pediatric Endocrinology
  • Molecular Biology
  • Metabolic Disorders

Background:

  • Obesity is a growing global health concern in children, often associated with metabolic complications like type 2 diabetes.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in various diseases, including metabolic disorders.
  • Inflammatory markers and specific proteins like sestrin-2 are increasingly recognized as players in the pathophysiology of obesity and diabetes.

Purpose of the Study:

  • To investigate the expression levels of microRNA-29a and microRNA-122 in obese children with and without diabetes mellitus.
  • To measure serum levels of sestrin-2 and inflammatory markers (interleukin-6, tumor necrosis factor-α, high-sensitivity C-reactive protein) in these pediatric populations.
  • To explore correlations between miRNA expressions, sestrin-2 levels, inflammatory markers, and various metabolic parameters.

Main Methods:

  • A case-control study involving 100 obese children with diabetes, 100 obese children without diabetes, and 100 healthy controls.
  • Quantitative real-time PCR was used to measure microRNA-29a and microRNA-122 expression.
  • Serum levels of sestrin-2, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and high-sensitivity C-reactive protein (hsCRP) were determined using appropriate assays.

Main Results:

  • Obese children with diabetes exhibited significantly higher expressions of microRNA-29a and microRNA-122, along with elevated IL-6, TNF-α, and hsCRP levels, compared to both obese non-diabetic and healthy children.
  • Serum sestrin-2 levels were significantly lower in obese children with diabetes.
  • MicroRNA expressions correlated positively with numerous metabolic and inflammatory markers, while sestrin-2 showed an inverse correlation.

Conclusions:

  • Elevated microRNA-29a and microRNA-122 expressions in obese children, particularly those with diabetes, suggest their potential involvement in the pathogenesis of childhood obesity and related metabolic dysfunction.
  • The findings propose that down-regulation of these microRNAs might be a therapeutic target, warranting further investigation.
Abstract